Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators

Ilaria Marrocco; Yosef Yarden

doi:10.3390/cancers15205009

Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators

Ilaria Marrocco, Yosef Yarden^*

^*Corresponding author

Weizmann Institute of Science

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	5009-N/A
Journal	Cancers
Volume	15
DOIs	https://doi.org/10.3390/cancers15205009
Publication status	Published - 2023

Keywords

EGFR
adaptive mutagenesis
kinase inhibitor
lung cancer
mutation
receptor tyrosine kinase
resistance to drugs

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/cancers15205009

Cite this

@article{db8040dc95dc4c0a8f0b8d5d06ee9786,

title = "Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators",

keywords = "EGFR, adaptive mutagenesis, kinase inhibitor, lung cancer, mutation, receptor tyrosine kinase, resistance to drugs, EGFR, adaptive mutagenesis, kinase inhibitor, lung cancer, mutation, receptor tyrosine kinase, resistance to drugs",

author = "Ilaria Marrocco and Yosef Yarden",

year = "2023",

doi = "10.3390/cancers15205009",

language = "English",

volume = "15",

pages = "5009--N/A",

journal = "Cancers",

issn = "2072-6694",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

}

TY - JOUR

T1 - Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators

AU - Marrocco, Ilaria

AU - Yarden, Yosef

PY - 2023

Y1 - 2023

KW - EGFR

KW - adaptive mutagenesis

KW - kinase inhibitor

KW - lung cancer

KW - mutation

KW - receptor tyrosine kinase

KW - resistance to drugs

KW - EGFR

KW - adaptive mutagenesis

KW - kinase inhibitor

KW - lung cancer

KW - mutation

KW - receptor tyrosine kinase

KW - resistance to drugs

UR - http://hdl.handle.net/10807/256554

U2 - 10.3390/cancers15205009

DO - 10.3390/cancers15205009

M3 - Article

SN - 2072-6694

VL - 15

SP - 5009-N/A

JO - Cancers

JF - Cancers

ER -

Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators

Keywords

UN SDGs

Access to Document

Other files and links

Cite this